Instituto Rosenbusch (BUE:ROSE) Change In Receivables: ARS284 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:ROSE Instituto Rosenbusch SA BUE:ROSE
22 GF Score
Price ARS157.00
GF Value ARS65.52
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Instituto Rosenbusch Change In Receivables?

Instituto Rosenbusch BUE:ROSE -0.32% 22 Change In Receivables is ARS284 Mil as of Mar. 2026. GuruFocus rates BUE:ROSE with a GF Score™ of 22/100 and a GF Value™ of ARS65.52 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Instituto Rosenbusch's change in receivables for the quarter that ended in Mar. 2026 was ARS332 Mil. It means Instituto Rosenbusch's Accounts Receivable declined by ARS332 Mil from Dec. 2025 to Mar. 2026 .

Instituto Rosenbusch's change in receivables for the fiscal year that ended in Dec. 2025 was ARS64 Mil. It means Instituto Rosenbusch's Accounts Receivable declined by ARS64 Mil from Dec. 2024 to Dec. 2025 .

Instituto Rosenbusch's Accounts Receivable for the quarter that ended in Mar. 2026 was ARS756 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Instituto Rosenbusch's Days Sales Outstanding for the three months ended in Mar. 2026 was 43.07.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Instituto Rosenbusch's liquidation value for the three months ended in Mar. 2026 was ARS-9,157 Mil.

Instituto Rosenbusch  (BUE:ROSE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Instituto Rosenbusch's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=755.914/1601.476*91
=43.07

2. In Ben Graham's calculation of liquidation value, Instituto Rosenbusch's accounts receivable are only considered to be worth 75% of book value:

Instituto Rosenbusch's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=158.342-11685.426+0.75 * 755.914+0.5 * 3606.323
=-9,157

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Instituto Rosenbusch Change In Receivables Related Terms

Instituto Rosenbusch Change In Receivables Historical Data

* Premium members only.

The historical data trend for Instituto Rosenbusch's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Instituto Rosenbusch Change In Receivables Chart

Instituto Rosenbusch Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 138.71 73.23 -507.99 1,474.50 63.98

Instituto Rosenbusch Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 112.00 134.20 -120.66 -61.56 332.08
BUE:ROSE
22GF Score
Instituto Rosenbusch SA BUE:ROSE
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Instituto Rosenbusch Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS284 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of ARS284 Mil mean?
Instituto Rosenbusch (BUE:ROSE) has a Change In Receivables of ARS284 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Instituto Rosenbusch and its competitors.
Is Instituto Rosenbusch's Change In Receivables too high?
Instituto Rosenbusch's current Change In Receivables is ARS284 Mil. Overall, Instituto Rosenbusch has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Instituto Rosenbusch's Change In Receivables compare to ZTS and UTHR?
Instituto Rosenbusch's Change In Receivables of ARS284 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Instituto Rosenbusch and its competitors. Instituto Rosenbusch's current Change In Receivables is ARS284 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Instituto Rosenbusch stock overvalued right now?
Based on GuruFocus' analysis, Instituto Rosenbusch (BUE:ROSE) is currently considered Significantly Overvalued. The stock's GF Value™ is ARS65.52, compared to a current price of ARS157.00 — trading 139.6% above its estimated fair value. The current Change In Receivables is ARS284 Mil. Instituto Rosenbusch's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Instituto Rosenbusch (BUE:ROSE), the current Change In Receivables is ARS284 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Instituto Rosenbusch (BUE:ROSE) Overvalued in 2026?

Based on GuruFocus' analysis, Instituto Rosenbusch stock appears to be overvalued. The current stock price of ARS157.00 is trading 139.6% above its estimated GF Value™ of ARS65.52. GuruFocus considers Instituto Rosenbusch to be Significantly Overvalued.

Key valuation signals for BUE:ROSE:

  • Change In Receivables: ARS284 Mil
  • GF Value™: ARS65.52 vs. price of ARS157.00 (139.6% above fair value)
  • GF Score™: 22/100 with 5 warning signs

No single metric tells the full story. See the BUE:ROSE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Instituto Rosenbusch Business Description

Address Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.
22GF Score

Get the complete analysis for BUE:ROSE

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS157.00
Price
ARS65.52
GF Value